Glycemic and Economic Outcomes in Elderly Patients with Type 2 Diabetes Initiating Dulaglutide Versus Basal Insulin in a Real-World Setting in the United States: The DISPEL-Advance Study

被引：0
|
作者：
Meredith Hoog
Rosirene Paczkowski
Ahong Huang
Rachel Halpern
Erin Buysman
Sydnie Stackland
Yiran Zhang
Ruth Wangia-Dixon
机构：
[1] Eli Lilly and Company,
[2] GSK,undefined
[3] Tigermed-BDM,undefined
[4] Optum Inc.,undefined
[5] Panalgo,undefined
[6] Elevance Health,undefined
来源：
Diabetes Therapy | 2023年 / 14卷
关键词：
Aged; Diabetes mellitus; Type 2; Retrospective studies; Glycated Hemoglobin; Dulaglutide; Insulin; Glucagon-like peptide-1 receptor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1947 / 1958
页数：11
相关论文
共 50 条
  • [31] METFORMIN DOSAGE PATTERNS IN TYPE 2 DIABETES PATIENTS IN A REAL-WORLD HEALTHCARE SETTING IN THE UNITED STATES
    Mahabaleshwarkar, R.
    DeSantis, A.
    VALUE IN HEALTH, 2019, 22 : S173 - S174
  • [32] Basal Insulin Dose Titration for Glycemic Control in Patients With Type 2 Diabetes Mellitus in Thailand: Results of the REWARDS Real-World Study
    Deerochanawong, Chaicharn
    Leelawattana, Rattana
    Kosachunhanun, Natapong
    Tantiwong, Puntip
    CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2020, 13
  • [33] Real-world glycemic outcomes in patients with type 2 diabetes initiating exenatide once weekly and liraglutide once daily: a retrospective cohort study
    Saunders, William B.
    Nguyen, Hiep
    Kalsekar, Iftekhar
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGET & THERAPY, 2016, 9 : 217 - 223
  • [34] Effects of basal and premixed insulin on glycemic control in type 2 diabetes patients based on multicenter prospective real-world data
    Peng, Ying
    Xu, Peihong
    Shi, Juan
    Zhang, Yifei
    Wang, Shujie
    Zheng, Qidong
    Wang, Yufan
    Ke, Tingyu
    Li, Li
    Zhao, Dong
    Dai, Yuancheng
    Dong, Qijuan
    Ji, Bangqun
    Xu, Fengmei
    Gu, Weiqiong
    Wang, Weiqing
    JOURNAL OF DIABETES, 2022, 14 (02) : 134 - 143
  • [35] The INITIATOR Study: Pilot Data on Real-World Clinical and Economic Outcomes in US Patients with Type 2 Diabetes Initiating Injectable Therapy
    Thayer, Sarah
    Wei, Wenhui
    Buysman, Erin
    Brekke, Lee
    Crown, William
    Grabner, Michael
    Raparla, Swetha
    Quimbo, Ralph
    Cziraky, Mark J.
    Hu, Wenli
    Cuddihy, Robert
    ADVANCES IN THERAPY, 2013, 30 (12) : 1128 - 1140
  • [36] The INITIATOR Study: Pilot Data on Real-World Clinical and Economic Outcomes in US Patients with Type 2 Diabetes Initiating Injectable Therapy
    Sarah Thayer
    Wenhui Wei
    Erin Buysman
    Lee Brekke
    William Crown
    Michael Grabner
    Swetha Raparla
    Ralph Quimbo
    Mark J. Cziraky
    Wenli Hu
    Robert Cuddihy
    Advances in Therapy, 2013, 30 : 1128 - 1140
  • [37] Comparing Effectiveness of Prandial Insulin and Glucagon-Like Peptide-1 Treatment Regimens in Patients With Type 2 Diabetes on Background Basal Insulin in a Real-World Setting in the United States
    Digenio, Andres
    Karve, Sudeep
    Candrilli, Sean
    Dalal, Mehul
    DIABETES, 2013, 62 : A264 - A265
  • [38] REAL-WORLD COMPARISON OF HEALTHCARE COSTS AMONG PATIENTS WITH TYPE 2 DIABETES TREATED WITH DULAGLUTIDE VS. LIRAGLUTIDE IN THE UNITED STATES
    Mody, R.
    Huang, Q.
    Yu, M.
    Patel, H.
    Zhao, R.
    Grabner, M.
    Lando, Fernandez L.
    VALUE IN HEALTH, 2018, 21 : S80 - S80
  • [39] Demographic and clinical profiles of type 2 diabetes mellitus patients initiating sitagliptin in the real-world setting
    Pawaskar, Manjiri
    Liu, Jinan
    Rajpathak, Swapnil
    Iglay, Kristy
    Engel, Samuel S.
    Hannachi, Hakima
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (07) : 1247 - 1253
  • [40] Real-world clinical and economic outcomes in patients with type 2 diabetes initiating glargine disposable pen vs. insulin detemir disposable pen in a US managed care setting
    Xie, L.
    Wei, W.
    Pan, C.
    Du, J.
    Baser, O.
    DIABETOLOGIA, 2011, 54 : S415 - S415
12345